APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wound Care Biologics

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.

Selected research

Market Analysis & Forecast

Global Wound Care Biologics Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchWound Care Biologics Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Wound Care Biologics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Wound Care Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wound Care Biologics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Wound Care Biologics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.

Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.

Read the full market overview

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.

In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.

Report Includes

This report presents an overview of global market for Wound Care Biologics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Wound Care Biologics, also provides the revenue of main regions and countries. Of the upcoming market potential for Wound Care Biologics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Wound Care Biologics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Wound Care Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Wound Care Biologics revenue, projected growth trends, production technology, application and end-user industry.

Wound Care Biologics Segment by Company

Smith and Nephew

Organogenesis

MiMedx

Integra

Osiris

Derma Sciences, Inc

Soluble Systems

Amnio Technology, LLC

Medline

Skye® Biologics

Alphatec Spine,Inc.

Pinnacle Transplant Technologies

Wound Care Biologics Segment by Type

Biologic Skin Substitutes

Enzyme Based Formulations

Growth Factors

Wound Care Biologics Segment by Application

Acute Wounds

Chronic Wounds

Surgical Wounds

Wound Care Biologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wound Care Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wound Care Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wound Care Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Wound Care Biologics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Wound Care Biologics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Wound Care Biologics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Wound Care Biologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biologic Skin Substitutes Major Player Table 3. Enzyme Based Formulations Major Player Table 4. Growth Factors Major Player Table 5. Global Wound Care Biologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Acute Wounds Major Player Table 7. Chronic Wounds Major Player Table 8. Surgical Wounds Major Player Table 9. Wound Care Biologics Industry Trends Table 10. Wound Care Biologics Industry Drivers Table 11. Wound Care Biologics Industry Opportunities and Challenges Table 12. Wound Care Biologics Industry Restraints Table 13. Global Wound Care Biologics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Wound Care Biologics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Wound Care Biologics Market Share by Region (2021-2026) Table 16. Global Wound Care Biologics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Wound Care Biologics Market Share by Region (2027-2032) Table 18. Global Wound Care Biologics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Wound Care Biologics Revenue Market Share by Players (2021-2026) Table 20. Global Wound Care Biologics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Wound Care Biologics Key Players Headquarters & Area Served Table 22. Global Wound Care Biologics Players, Product Type & Application Table 23. Global Wound Care Biologics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Wound Care Biologics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Wound Care Biologics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Wound Care Biologics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Wound Care Biologics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Wound Care Biologics Revenue Market Share by Type (2021-2026) Table 30. Global Wound Care Biologics Revenue Market Share by Type (2027-2032) Table 31. Global Wound Care Biologics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Wound Care Biologics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Wound Care Biologics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Wound Care Biologics Revenue Market Share by Application (2021-2026) Table 35. Global Wound Care Biologics Revenue Market Share by Application (2027-2032) Table 36. Smith and Nephew Company Information Table 37. Smith and Nephew Business Overview Table 38. Smith and Nephew Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Smith and Nephew Wound Care Biologics Product Portfolio Table 40. Smith and Nephew Recent Development Table 41. Organogenesis Company Information Table 42. Organogenesis Business Overview Table 43. Organogenesis Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Organogenesis Wound Care Biologics Product Portfolio Table 45. Organogenesis Recent Development Table 46. MiMedx Company Information Table 47. MiMedx Business Overview Table 48. MiMedx Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. MiMedx Wound Care Biologics Product Portfolio Table 50. MiMedx Recent Development Table 51. Integra Company Information Table 52. Integra Business Overview Table 53. Integra Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Integra Wound Care Biologics Product Portfolio Table 55. Integra Recent Development Table 56. Osiris Company Information Table 57. Osiris Business Overview Table 58. Osiris Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Osiris Wound Care Biologics Product Portfolio Table 60. Osiris Recent Development Table 61. Derma Sciences, Inc Company Information Table 62. Derma Sciences, Inc Business Overview Table 63. Derma Sciences, Inc Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Derma Sciences, Inc Wound Care Biologics Product Portfolio Table 65. Derma Sciences, Inc Recent Development Table 66. Soluble Systems Company Information Table 67. Soluble Systems Business Overview Table 68. Soluble Systems Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Soluble Systems Wound Care Biologics Product Portfolio Table 70. Soluble Systems Recent Development Table 71. Amnio Technology, LLC Company Information Table 72. Amnio Technology, LLC Business Overview Table 73. Amnio Technology, LLC Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Amnio Technology, LLC Wound Care Biologics Product Portfolio Table 75. Amnio Technology, LLC Recent Development Table 76. Medline Company Information Table 77. Medline Business Overview Table 78. Medline Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Medline Wound Care Biologics Product Portfolio Table 80. Medline Recent Development Table 81. Skye® Biologics Company Information Table 82. Skye® Biologics Business Overview Table 83. Skye® Biologics Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Skye® Biologics Wound Care Biologics Product Portfolio Table 85. Skye® Biologics Recent Development Table 86. Alphatec Spine,Inc. Company Information Table 87. Alphatec Spine,Inc. Business Overview Table 88. Alphatec Spine,Inc. Wound Care Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Alphatec Spine,Inc. Wound Care Biologics Product Portfolio Table 90. Alphatec Spine,Inc. Recent Development Table 91. Pinnacle Transplant Technologies Company Information Table 92. Pinnacle Transplant Technologies Business Overview Table 93. Pinnacle Transplant Technologies Wound Care Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio Table 95. Pinnacle Transplant Technologies Recent Development Table 96. North America Wound Care Biologics Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Wound Care Biologics Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Wound Care Biologics Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Wound Care Biologics Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Wound Care Biologics Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Wound Care Biologics Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Wound Care Biologics Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Wound Care Biologics Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Wound Care Biologics Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Wound Care Biologics Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Wound Care Biologics Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Wound Care Biologics Revenue by Country (US$ Million) & (2027-2032) Table 110. China Wound Care Biologics Revenue by Type (2021-2026) & (US$ Million) Table 111. China Wound Care Biologics Revenue by Type (2027-2032) & (US$ Million) Table 112. China Wound Care Biologics Revenue by Application (2021-2026) & (US$ Million) Table 113. China Wound Care Biologics Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Wound Care Biologics Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Wound Care Biologics Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Wound Care Biologics Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Wound Care Biologics Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Wound Care Biologics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Wound Care Biologics Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Wound Care Biologics Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Wound Care Biologics Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Wound Care Biologics Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Wound Care Biologics Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Wound Care Biologics Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Wound Care Biologics Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Wound Care Biologics Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Wound Care Biologics Image Figure 2. Global Wound Care Biologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wound Care Biologics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biologic Skin Substitutes Image Figure 5. Enzyme Based Formulations Image Figure 6. Growth Factors Image Figure 7. Global Wound Care Biologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Wound Care Biologics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Acute Wounds Image Figure 10. Chronic Wounds Image Figure 11. Surgical Wounds Image Figure 12. Global Wound Care Biologics Market Size (US$ Million) & (2021-2032) Figure 13. Global Wound Care Biologics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Wound Care Biologics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Wound Care Biologics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Wound Care Biologics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Wound Care Biologics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Wound Care Biologics Revenue Market Share by Type (2021-2032) Figure 20. Global Wound Care Biologics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Wound Care Biologics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Wound Care Biologics Revenue Market Share by Application (2021-2032) Figure 23. North America Wound Care Biologics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Wound Care Biologics Revenue Share by Type (2021-2032) Figure 25. North America Wound Care Biologics Revenue Share by Application (2021-2032) Figure 26. North America Wound Care Biologics Revenue Share by Country (2021-2032) Figure 27. United States Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Wound Care Biologics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Wound Care Biologics Revenue Share by Type (2021-2032) Figure 32. Europe Wound Care Biologics Revenue Share by Application (2021-2032) Figure 33. Europe Wound Care Biologics Revenue Share by Country (2021-2032) Figure 34. Germany Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Wound Care Biologics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Wound Care Biologics Revenue Share by Type (2021-2032) Figure 44. China Wound Care Biologics Revenue Share by Application (2021-2032) Figure 45. Asia Wound Care Biologics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Wound Care Biologics Revenue Share by Type (2021-2032) Figure 47. Asia Wound Care Biologics Revenue Share by Application (2021-2032) Figure 48. Asia Wound Care Biologics Revenue Share by Region (2021-2032) Figure 49. Japan Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Wound Care Biologics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Wound Care Biologics Revenue Share by Type (2021-2032) Figure 57. SAMEA Wound Care Biologics Revenue Share by Application (2021-2032) Figure 58. SAMEA Wound Care Biologics Revenue Share by Country (2021-2032) Figure 59. Brazil Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Wound Care Biologics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth Factors
Applications
  • Acute Wounds
  • Chronic Wounds
  • Surgical Wounds
Companies covered
  • Smith and Nephew
  • Organogenesis
  • MiMedx
  • Integra
  • Osiris
  • Derma Sciences, Inc
  • Soluble Systems
  • Amnio Technology, LLC
  • Medline
  • Skye® Biologics
  • Alphatec Spine,Inc.
  • Pinnacle Transplant Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Wound Care Biologics Market by Type
  3. 1.2.1 Global Wound Care Biologics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biologic Skin Substitutes
  5. 1.2.3 Enzyme Based Formulations
  6. 1.2.4 Growth Factors
  7. 1.3 Wound Care Biologics Market by Application
  8. 1.3.1 Global Wound Care Biologics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Acute Wounds
  10. 1.3.3 Chronic Wounds
  11. 1.3.4 Surgical Wounds
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Wound Care Biologics Market Dynamics
  1. 2.1 Wound Care Biologics Industry Trends
  2. 2.2 Wound Care Biologics Industry Drivers
  3. 2.3 Wound Care Biologics Industry Opportunities and Challenges
  4. 2.4 Wound Care Biologics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Wound Care Biologics Market Perspective (2021-2032)
  2. 3.2 Global Wound Care Biologics Growth Trends by Region
  3. 3.2.1 Global Wound Care Biologics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Wound Care Biologics Market Size by Region (2021-2026)
  5. 3.2.3 Global Wound Care Biologics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Wound Care Biologics Revenue by Players
  2. 4.1.1 Global Wound Care Biologics Revenue by Players (2021-2026)
  3. 4.1.2 Global Wound Care Biologics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Wound Care Biologics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Wound Care Biologics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Wound Care Biologics Key Players Headquarters & Area Served
  7. 4.4 Global Wound Care Biologics Players, Product Type & Application
  8. 4.5 Global Wound Care Biologics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Wound Care Biologics Market CR5 and HHI
  11. 4.6.3 2025 Wound Care Biologics Tier 1, Tier 2, and Tier 3
5 Wound Care Biologics Market Size by Type
  1. 5.1 Global Wound Care Biologics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Wound Care Biologics Revenue by Type (2021-2032)
  3. 5.3 Global Wound Care Biologics Revenue Market Share by Type (2021-2032)
6 Wound Care Biologics Market Size by Application
  1. 6.1 Global Wound Care Biologics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Wound Care Biologics Revenue by Application (2021-2032)
  3. 6.3 Global Wound Care Biologics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Smith and Nephew
  2. 7.1.1 Smith and Nephew Company Information
  3. 7.1.2 Smith and Nephew Business Overview
  4. 7.1.3 Smith and Nephew Wound Care Biologics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Smith and Nephew Wound Care Biologics Product Portfolio
  6. 7.1.5 Smith and Nephew Recent Developments
  7. 7.2 Organogenesis
  8. 7.2.1 Organogenesis Company Information
  9. 7.2.2 Organogenesis Business Overview
  10. 7.2.3 Organogenesis Wound Care Biologics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Organogenesis Wound Care Biologics Product Portfolio
  12. 7.2.5 Organogenesis Recent Developments
  13. 7.3 MiMedx
  14. 7.3.1 MiMedx Company Information
  15. 7.3.2 MiMedx Business Overview
  16. 7.3.3 MiMedx Wound Care Biologics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MiMedx Wound Care Biologics Product Portfolio
  18. 7.3.5 MiMedx Recent Developments
  19. 7.4 Integra
  20. 7.4.1 Integra Company Information
  21. 7.4.2 Integra Business Overview
  22. 7.4.3 Integra Wound Care Biologics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Integra Wound Care Biologics Product Portfolio
  24. 7.4.5 Integra Recent Developments
  25. 7.5 Osiris
  26. 7.5.1 Osiris Company Information
  27. 7.5.2 Osiris Business Overview
  28. 7.5.3 Osiris Wound Care Biologics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Osiris Wound Care Biologics Product Portfolio
  30. 7.5.5 Osiris Recent Developments
  31. 7.6 Derma Sciences, Inc
  32. 7.6.1 Derma Sciences, Inc Company Information
  33. 7.6.2 Derma Sciences, Inc Business Overview
  34. 7.6.3 Derma Sciences, Inc Wound Care Biologics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Derma Sciences, Inc Wound Care Biologics Product Portfolio
  36. 7.6.5 Derma Sciences, Inc Recent Developments
  37. 7.7 Soluble Systems
  38. 7.7.1 Soluble Systems Company Information
  39. 7.7.2 Soluble Systems Business Overview
  40. 7.7.3 Soluble Systems Wound Care Biologics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Soluble Systems Wound Care Biologics Product Portfolio
  42. 7.7.5 Soluble Systems Recent Developments
  43. 7.8 Amnio Technology, LLC
  44. 7.8.1 Amnio Technology, LLC Company Information
  45. 7.8.2 Amnio Technology, LLC Business Overview
  46. 7.8.3 Amnio Technology, LLC Wound Care Biologics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Amnio Technology, LLC Wound Care Biologics Product Portfolio
  48. 7.8.5 Amnio Technology, LLC Recent Developments
  49. 7.9 Medline
  50. 7.9.1 Medline Company Information
  51. 7.9.2 Medline Business Overview
  52. 7.9.3 Medline Wound Care Biologics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Medline Wound Care Biologics Product Portfolio
  54. 7.9.5 Medline Recent Developments
  55. 7.10 Skye® Biologics
  56. 7.10.1 Skye® Biologics Company Information
  57. 7.10.2 Skye® Biologics Business Overview
  58. 7.10.3 Skye® Biologics Wound Care Biologics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Skye® Biologics Wound Care Biologics Product Portfolio
  60. 7.10.5 Skye® Biologics Recent Developments
  61. 7.11 Alphatec Spine,Inc.
  62. 7.11.1 Alphatec Spine,Inc. Company Information
  63. 7.11.2 Alphatec Spine,Inc. Business Overview
  64. 7.11.3 Alphatec Spine,Inc. Wound Care Biologics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Alphatec Spine,Inc. Wound Care Biologics Product Portfolio
  66. 7.11.5 Alphatec Spine,Inc. Recent Developments
  67. 7.12 Pinnacle Transplant Technologies
  68. 7.12.1 Pinnacle Transplant Technologies Company Information
  69. 7.12.2 Pinnacle Transplant Technologies Business Overview
  70. 7.12.3 Pinnacle Transplant Technologies Wound Care Biologics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio
  72. 7.12.5 Pinnacle Transplant Technologies Recent Developments
8 North America
  1. 8.1 North America Wound Care Biologics Revenue (2021-2032)
  2. 8.2 North America Wound Care Biologics Revenue by Type (2021-2032)
  3. 8.2.1 North America Wound Care Biologics Revenue by Type (2021-2026)
  4. 8.2.2 North America Wound Care Biologics Revenue by Type (2027-2032)
  5. 8.3 North America Wound Care Biologics Revenue Share by Type (2021-2032)
  6. 8.4 North America Wound Care Biologics Revenue by Application (2021-2032)
  7. 8.4.1 North America Wound Care Biologics Revenue by Application (2021-2026)
  8. 8.4.2 North America Wound Care Biologics Revenue by Application (2027-2032)
  9. 8.5 North America Wound Care Biologics Revenue Share by Application (2021-2032)
  10. 8.6 North America Wound Care Biologics Revenue by Country
  11. 8.6.1 North America Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Wound Care Biologics Revenue by Country (2021-2026)
  13. 8.6.3 North America Wound Care Biologics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Wound Care Biologics Revenue (2021-2032)
  2. 9.2 Europe Wound Care Biologics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Wound Care Biologics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Wound Care Biologics Revenue by Type (2027-2032)
  5. 9.3 Europe Wound Care Biologics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Wound Care Biologics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Wound Care Biologics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Wound Care Biologics Revenue by Application (2027-2032)
  9. 9.5 Europe Wound Care Biologics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Wound Care Biologics Revenue by Country
  11. 9.6.1 Europe Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Wound Care Biologics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Wound Care Biologics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Wound Care Biologics Revenue (2021-2032)
  2. 10.2 China Wound Care Biologics Revenue by Type (2021-2032)
  3. 10.2.1 China Wound Care Biologics Revenue by Type (2021-2026)
  4. 10.2.2 China Wound Care Biologics Revenue by Type (2027-2032)
  5. 10.3 China Wound Care Biologics Revenue Share by Type (2021-2032)
  6. 10.4 China Wound Care Biologics Revenue by Application (2021-2032)
  7. 10.4.1 China Wound Care Biologics Revenue by Application (2021-2026)
  8. 10.4.2 China Wound Care Biologics Revenue by Application (2027-2032)
  9. 10.5 China Wound Care Biologics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Wound Care Biologics Revenue (2021-2032)
  2. 11.2 Asia Wound Care Biologics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Wound Care Biologics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Wound Care Biologics Revenue by Type (2027-2032)
  5. 11.3 Asia Wound Care Biologics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Wound Care Biologics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Wound Care Biologics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Wound Care Biologics Revenue by Application (2027-2032)
  9. 11.5 Asia Wound Care Biologics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Wound Care Biologics Revenue by Country
  11. 11.6.1 Asia Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Wound Care Biologics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Wound Care Biologics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Wound Care Biologics Revenue (2021-2032)
  2. 12.2 SAMEA Wound Care Biologics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Wound Care Biologics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Wound Care Biologics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Wound Care Biologics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Wound Care Biologics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Wound Care Biologics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Wound Care Biologics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Wound Care Biologics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Wound Care Biologics Revenue by Country
  11. 12.6.1 SAMEA Wound Care Biologics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Wound Care Biologics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Wound Care Biologics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst